Go Pro
NASDAQ:YI

111 (YI) Stock Price, News & Analysis

111 logo
$3.59 +0.14 (+4.06%)
Closing price 09/11/2026 03:59 PM Eastern
Extended Trading
$3.57 -0.02 (-0.50%)
As of 09/11/2026 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About 111 Stock (NASDAQ:YI)

Advanced

Key Stats

Today's Range
$3.20
$3.65
50-Day Range
$3.13
$4.20
52-Week Range
$2.48
$11.17
Volume
35,006 shs
Average Volume
10,720 shs
Market Capitalization
$31.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

111, Inc. (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc. aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc.’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods. The platform offers specialized services for prescription fulfillment, enabling users to upload medical prescriptions securely and receive licensed medications through certified pharmacy partners. In addition to its core pharmaceutical offerings, the company features a curated selection of imported wellness and beauty brands sourced from markets such as the United States, Europe, and Japan.

With a focus on cross-border e-commerce, 111, Inc. partners with domestic manufacturers and international suppliers to ensure product authenticity and quality control. The company operates strategically located warehouses to facilitate efficient order processing and delivery, leveraging both direct shipping from overseas distributors and local inventory hubs. Its digital infrastructure supports real-time inventory tracking, customer support, and data-driven recommendations to enhance the consumer experience.

Founded in 2010 and headquartered in Shanghai, 111, Inc. has grown alongside China’s expanding digital healthcare market. Its management team brings together expertise in online retail, supply chain logistics, and regulatory compliance to navigate the complexities of pharmaceutical distribution. Through ongoing platform enhancements and strategic partnerships, 111, Inc. continues to expand its reach and service offerings in China’s rapidly evolving healthcare e-commerce landscape.

AI Generated. May Contain Errors.

111 Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

YI MarketRank™: 

111 scored higher than 12% of companies evaluated by MarketBeat, and ranked 863rd out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    111 has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    111 has only been the subject of 1 research reports in the past 90 days.

  • Read more about 111's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of 111 is -2.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of 111 is -2.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about 111's valuation and earnings.
  • Percentage of Shares Shorted

    0.20% of the float of 111 has been sold short.
  • Short Interest Ratio / Days to Cover

    111 has a short interest ratio ("days to cover") of 0.79, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 111 has recently increased by 50.96%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    111 does not currently pay a dividend.

  • Dividend Growth

    111 does not have a long track record of dividend growth.

  • News Sentiment

    111 has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for 111 this week, compared to 2 articles on an average week.
  • Search Interest

    3 people have searched for YI on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, 111 insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $23,644.00 in company stock.

  • Percentage Held by Insiders

    43.90% of the stock of 111 is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    21.32% of the stock of 111 is held by institutions.

  • Read more about 111's insider trading history.
Receive YI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 111 and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

YI Stock News Headlines

111 Inc. ADR
111, Inc. Sponsored ADR
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
111 Inc Share Price | NASDAQ: YI Stock - Investing.com UK
See More Headlines

YI Stock Analysis - Frequently Asked Questions

111's stock was trading at $2.56 on January 1st, 2026. Since then, YI stock has increased by 40.2% and is now trading at $3.59.

111, Inc. Sponsored ADR (NASDAQ:YI) posted its earnings results on Wednesday, September, 17th. The company reported ($0.40) EPS for the quarter. The firm had revenue of $447.51 million for the quarter.

111 shares reverse split before market open on Friday, January 24th 2025.The 1-10 reverse split was announced on Wednesday, January 8th 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, January 23rd 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

111 (YI) raised $108 million in an initial public offering (IPO) on Wednesday, September 12th 2018. The company issued 7,175,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Citigroup and CICC served as the underwriters for the IPO.

Shares of YI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that 111 investors own include NVIDIA (NVDA), Teladoc Health (TDOC), Innovative Industrial Properties (IIPR), Magnite (MGNI), Roku (ROKU), Twilio (TWLO).

Company Calendar

Last Earnings
9/17/2025
Today
9/13/2026
Next Earnings (Estimated)
11/26/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Distributors
Current Symbol
NASDAQ:YI
CIK
1738906
Fax
N/A
Employees
1,063
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.40)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.65 million
Net Margins
-0.76%
Pretax Margin
-0.38%
Return on Equity
N/A
Return on Assets
-3.80%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.08
Quick Ratio
0.49

Sales & Book Value

Annual Sales
$1.80 billion
Price / Sales
0.02
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($11.74) per share
Price / Book
-0.31

Miscellaneous

Outstanding Shares
8,790,000
Free Float
4,928,000
Market Cap
$31.56 million
Optionable
Optionable
Beta
0.64
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:YI) was last updated on 9/13/2026 by MarketBeat.com Staff.
From Our Partners